Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Tendinitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-55
SponsorCairo University

About this trial

This study aims to investigate the effect of TECAR therapy on pain, shoulder range of motion, functional disability, and handgrip strength in patients with grade II supraspinatus tendinitis.

Eligibility criteria

Qualifiers

Supraspinatus Tendinitis grade II based on Neer's classification, confirmed by special tests, signs, and symptoms of grade I and II Supraspinatus Tendinitis for the past month, and taking non-steroidal anti-inflammatory drugs as suggested by the physician.

All patients will have a body mass index between 18.5 and 29.9 kg/m².

Disqualifiers

Other grades of Supraspinatus Tendinitis.

Any past shoulder surgical interventions.

Instability of the shoulder joint due to other reasons, Acromioclavicular Joint Arthritis.

Non-cooperative subjects.

Trial design

Treatments tested in this trial

  • Conventional treatment
  • TECAR (Transfer of Energy Capacitive and Resistive) Therapy

Treatment groups

46 Participants
are divided into 2 treatment groups

Sponsors and collaborators